X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (172) 172
Patent (15) 15
Newspaper Article (10) 10
Publication (10) 10
Book Chapter (3) 3
Conference Proceeding (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (70) 70
humans (68) 68
male (46) 46
hematology (45) 45
female (44) 44
aged (39) 39
middle aged (34) 34
oncology (30) 30
adult (25) 25
survival (25) 25
multiple myeloma (20) 20
multiple myeloma - drug therapy (20) 20
therapy (20) 20
abridged index medicus (19) 19
aged, 80 and over (19) 19
treatment outcome (18) 18
chemistry (15) 15
disease-free survival (15) 15
metallurgy (15) 15
multiple myeloma - mortality (14) 14
stem-cell transplantation (14) 14
analysis (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
prognosis (13) 13
bortezomib (12) 12
spain (12) 12
biochemistry (11) 11
care and treatment (11) 11
chemotherapy (11) 11
follow-up studies (11) 11
multiple myeloma - pathology (11) 11
multiple myeloma - therapy (11) 11
transplantation (11) 11
tropical medicine (11) 11
survival rate (10) 10
time factors (10) 10
human necessities (9) 9
hygiene (9) 9
immunophenotyping (9) 9
medical or veterinary science (9) 9
melphalan - administration & dosage (9) 9
minimal residual disease (9) 9
multiple myeloma - diagnosis (9) 9
multiple myeloma - genetics (9) 9
patients (9) 9
peptides (9) 9
prednisone - administration & dosage (9) 9
preparations for medical, dental, or toilet purposes (9) 9
retrospective studies (9) 9
risk factors (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
cuba (8) 8
dexamethasone - administration & dosage (8) 8
enzymes (8) 8
expression (8) 8
high-dose therapy (8) 8
lenalidomide (8) 8
microbiology (8) 8
organic chemistry (8) 8
thalidomide - administration & dosage (8) 8
transplantation, autologous (8) 8
antineoplastic agents - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
beer (7) 7
boronic acids - administration & dosage (7) 7
clinical trials (7) 7
dexamethasone (7) 7
enzymology (7) 7
flow cytometry (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
medicine & public health (7) 7
melphalan (7) 7
mutation or genetic engineering (7) 7
plasma-cells (7) 7
pyrazines - administration & dosage (7) 7
remission induction (7) 7
spirits (7) 7
survival analysis (7) 7
technical subjects covered by former us classification (7) 7
technical subjects covered by former uspc (7) 7
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (7) 7
thalidomide (7) 7
thalidomide - analogs & derivatives (7) 7
vinegar (7) 7
wine (7) 7
adolescent (6) 6
antineoplastic agents (6) 6
cancer (6) 6
criteria (6) 6
hematology, oncology and palliative medicine (6) 6
kaplan-meier estimate (6) 6
leukemia (6) 6
life sciences (6) 6
registries (6) 6
stem cell transplantation (6) 6
stem cells (6) 6
age factors (5) 5
antimitotic agents (5) 5
antineoplastic agents - therapeutic use (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 438 - 447
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 10/2017, Volume 143, Issue 10, pp. 2059 - 2066
Journal Article
Journal Article
Cancer Medicine, ISSN 2045-7634, 07/2015, Volume 4, Issue 7, pp. 995 - 1002
Chronic myeloid leukemia patients display heterogeneous responses to imatinib. Survival depends on baseline clinical characteristics (including prognostic... 
chronic myeloid leukemia | imatinib | BCR‐ABL/ABL ratio | dasatinib | nilotinib | Nilotinib | Dasatinib | Imatinib | BCR-ABL/ABL ratio | Chronic myeloid leukemia | SURVIVAL | MANAGEMENT | CML | ONCOLOGY | RECOMMENDATIONS | CYTOGENETIC RESPONSE | FOLLOW-UP | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Young Adult | Imatinib Mesylate - therapeutic use | Time Factors | Treatment Failure | Imatinib Mesylate - administration & dosage | Aged, 80 and over | Adult | Female | Transcription, Genetic | Retrospective Studies | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Treatment Outcome | Protein Kinase Inhibitors - administration & dosage | Retreatment | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Adolescent | Genes, abl | Aged | Drug Substitution | Antimitotic agents | Tyrosine | Care and treatment | Patient outcomes | Analysis | Phenols | Antineoplastic agents | BCR protein | Myeloid leukemia | Leukemia | Clinical trials | Multivariate analysis | Patients | Survival | Polymerase chain reaction | Intolerance | Motivation | Medical prognosis | Cytogenetics | Protein-tyrosine kinase | Boards of directors | Index Medicus | ABL ratio | Clinical Cancer Research | BCR-ABL
Journal Article
Journal Article
Journal Article
Outbreak of acute haemorrhagic conjunctivitis in Cuba, 12/1999
Acute haemorrhagic conjunctivitis (AHC) is a highly contagious eye disease, which appeared for the first time in Africa in 1969. The causative agent was... 
acute haemorrhagic conjunctivitis - Coxsackievirus A24 - Cuba
Journal
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 12, pp. 1627 - 1633
Journal Article
Southwestern Naturalist, ISSN 0038-4909, 09/2016, Volume 61, Issue 3, pp. 241 - 245
Mexico has a high amphibian diversity (360 species), but several regions of the country remain relatively poorly studied. We document the anuran fauna for the... 
PHYLOGENY | RANA | AMPHIBIANS | SEDIMENTS | ECOLOGY | IRON | BIODIVERSITY CONSERVATION | EXTINCTION | WORLD | DECLINES | ESTUARY | FROGS | Frogs | Animal populations | Research | Mining | Studies | Rivers | Sea level | Documentation
Journal Article
Blood, ISSN 0006-4971, 09/2012, Volume 120, Issue 13, pp. 2581 - 2588
Journal Article
Journal of the Marine Biological Association of the United Kingdom, ISSN 0025-3154, 09/2016, Volume 96, Issue 6, pp. 1235 - 1242
The ommastrephid squid, Illex coindetii, is one of the most abundant cephalopods in the Mediterranean Sea and an important predator in the ecosystem. In the... 
Illex coindetii | trophic ecology | stomach content analysis | stable isotope analysis | Western Mediterranean | isotopic mixing model | BEAKS | STABLE-ISOTOPES | CEPHALOPODA OMMASTREPHIDAE | DIET | MARINE & FRESHWATER BIOLOGY | INCLUDING GIANT | FISH | DISCRIMINATION FACTORS | CATALAN SEA | FOOD
Journal Article